Cerebrospinal Fluid Biomarkers in Neurodegenerative Movement Disorders

Cerebrospinal fluid matrix metalloproteinases in combination with markers reflecting subcortical and cortical alterations differentiate between Vascular dementia

Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson's disease.. Acta

On-line RP-HPLC was carried out over a 180 min gradient on an Ultimate 3000 RSLC nano-flow system, allowing for a high degree of peptide separation prior to ms/ms-analysis

Advances in the field of bio analysis, primarily in mass spectrometry but also in chromatographic separation, may have led to analytical systems now being sufficiently sensitive

Abbreviations Aβ, β amyloid AD, Alzheimer’s disease ADAM, A Disintegrin And Metalloproteinase APOE, Apolipoprotein E APP, amyloid precursor protein AUROC, area under the

When evaluating the diagnostic performance of T-tau and T-tau/P-tau ratio using the test results at the time point closest to death, another 7 CJD patients were classified

The cross-sectional part included an HIV-positive group (n = 252) divided into six subgroups: Four groups of neuroasymptomatic (NA) patients without treatment,

This thesis evaluates biomarkers related to: neuronal injury (neurofilament light chain protein (NFL) and total tau (t-tau)); immune activation (neopterin); and altered